Owen Wallace
Chief Tech/Sci/R&D Officer at MONTE ROSA THERAPEUTICS, INC.
Net worth: 37 125 $ as of 31/03/2024
Profile
Owen Wallace is currently the Chief Scientific Officer at Monte Rosa Therapeutics, Inc. Prior to this, he was the Chief Scientific Officer at Fulcrum Therapeutics, Inc. from 2017 to 2021.
He was also the Head-Global Discovery Chemistry at Novartis Institutes for Biomedical Research, Inc. from 2013 to 2017.
From 2002 to 2013, he worked at Eli Lilly & Co. as a Senior Director.
He also worked as a Senior Director-Discovery Chemistry Research at Lilly Research Centre Ltd.
He received his graduate and doctorate degrees from Yale University and his undergraduate degree from University College Cork.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
02/01/2024 | 5,266 ( 0.01% ) | 37 125 $ | 31/03/2024 |
Owen Wallace active positions
Companies | Position | Start |
---|---|---|
MONTE ROSA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/02/2021 |
Former positions of Owen Wallace
Companies | Position | End |
---|---|---|
FULCRUM THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 05/02/2021 |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/04/2017 |
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/06/2013 |
Lilly Research Centre Ltd. | Corporate Officer/Principal | - |
Training of Owen Wallace
Yale University | Doctorate Degree |
University College Cork | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
FULCRUM THERAPEUTICS, INC. | Health Technology |
MONTE ROSA THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
Lilly Research Centre Ltd. |
- Stock Market
- Insiders
- Owen Wallace